These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 29324842)

  • 1. Effect of analytical treatment interruption and reinitiation of antiretroviral therapy on HIV reservoirs and immunologic parameters in infected individuals.
    Clarridge KE; Blazkova J; Einkauf K; Petrone M; Refsland EW; Justement JS; Shi V; Huiting ED; Seamon CA; Lee GQ; Yu XG; Moir S; Sneller MC; Lichterfeld M; Chun TW
    PLoS Pathog; 2018 Jan; 14(1):e1006792. PubMed ID: 29324842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipid Metabolism Is Associated with Time to HIV Rebound upon Treatment Interruption.
    Giron LB; Papasavvas E; Yin X; Goldman AR; Tang HY; Palmer CS; Landay AL; Li JZ; Koethe JR; Mounzer K; Kostman JR; Liu Q; Montaner LJ; Abdel-Mohsen M
    mBio; 2021 Feb; 12(1):. PubMed ID: 33622719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Short-Term Antiretroviral Therapy Interruption on Levels of Integrated HIV DNA.
    Strongin Z; Sharaf R; VanBelzen DJ; Jacobson JM; Connick E; Volberding P; Skiest DJ; Gandhi RT; Kuritzkes DR; O'Doherty U; Li JZ
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption.
    Vibholm LK; Lorenzi JCC; Pai JA; Cohen YZ; Oliveira TY; Barton JP; Garcia Noceda M; Lu CL; Ablanedo-Terrazas Y; Del Rio Estrada PM; Reyes-Teran G; Tolstrup M; Denton PW; Damsgaard T; Søgaard OS; Nussenzweig MC
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30700598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical antiretroviral therapy interruption does not irreversibly change preinterruption levels of cellular HIV.
    Papasavvas E; Lada SM; Joseph J; Yin X; Liu Q; Azzoni L; Mounzer K; Kostman JR; Richman D; Montaner LJ
    AIDS; 2018 Aug; 32(13):1763-1772. PubMed ID: 30045057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 latent reservoir size and diversity are stable following brief treatment interruption.
    Salantes DB; Zheng Y; Mampe F; Srivastava T; Beg S; Lai J; Li JZ; Tressler RL; Koup RA; Hoxie J; Abdel-Mohsen M; Sherrill-Mix S; McCormick K; Overton ET; Bushman FD; Learn GH; Siliciano RF; Siliciano JM; Tebas P; Bar KJ
    J Clin Invest; 2018 Jul; 128(7):3102-3115. PubMed ID: 29911997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of long-term antiretroviral therapy interruption and resumption on viral reservoir in HIV-1 infected patients.
    Montserrat M; Plana M; Guardo AC; Andrés C; Climent N; Gallart T; Leal L; Gatell JM; Sánchez-Palomino S; García F
    AIDS; 2017 Aug; 31(13):1895-1897. PubMed ID: 28590333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virologic and Immunologic Features of Simian Immunodeficiency Virus Control Post-ART Interruption in Rhesus Macaques.
    Strongin Z; Micci L; Fromentin R; Harper J; McBrien J; Ryan E; Shenvi N; Easley K; Chomont N; Silvestri G; Paiardini M
    J Virol; 2020 Jul; 94(14):. PubMed ID: 32350073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment.
    Aamer HA; McClure J; Ko D; Maenza J; Collier AC; Coombs RW; Mullins JI; Frenkel LM
    PLoS Pathog; 2020 Aug; 16(8):e1008791. PubMed ID: 32841299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.
    Henrich TJ; Hatano H; Bacon O; Hogan LE; Rutishauser R; Hill A; Kearney MF; Anderson EM; Buchbinder SP; Cohen SE; Abdel-Mohsen M; Pohlmeyer CW; Fromentin R; Hoh R; Liu AY; McCune JM; Spindler J; Metcalf-Pate K; Hobbs KS; Thanh C; Gibson EA; Kuritzkes DR; Siliciano RF; Price RW; Richman DD; Chomont N; Siliciano JD; Mellors JW; Yukl SA; Blankson JN; Liegler T; Deeks SG
    PLoS Med; 2017 Nov; 14(11):e1002417. PubMed ID: 29112956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virological remission after antiretroviral therapy interruption in female African HIV seroconverters.
    Gossez M; Martin GE; Pace M; Ramjee G; Premraj A; Kaleebu P; Rees H; Inshaw J; Stöhr W; Meyerowitz J; Hopkins E; Jones M; Hurst J; Porter K; Babiker A; Fidler S; Frater J;
    AIDS; 2019 Feb; 33(2):185-197. PubMed ID: 30325764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Treatment Interruption on HIV Reservoirs and Lymphocyte Subsets in Individuals Who Initiated Antiretroviral Therapy During the Early Phase of Infection.
    Huiting ED; Gittens K; Justement JS; Shi V; Blazkova J; Benko E; Kovacs C; Wender PA; Moir S; Sneller MC; Fauci AS; Chun TW
    J Infect Dis; 2019 Jun; 220(2):270-274. PubMed ID: 30840763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordance between HIV-1 Population in Plasma at Rebound after Structured Treatment Interruption and Archived Provirus Population in Peripheral Blood Mononuclear Cells.
    Hendricks CM; Cash MN; Tagliamonte MS; Riva A; Brander C; Llano A; Salemi M; Stevenson M; Mavian C
    Microbiol Spectr; 2022 Aug; 10(4):e0135322. PubMed ID: 35699458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Proviral DNA in Circulating Cells Correlates with Plasma Viral Rebound in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Antiretroviral Therapy Interruption.
    Ziani W; Shao J; Wang X; Russell-Lodrigue K; Liu YZ; Montaner LJ; Veazey RS; Xu H
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral Therapy.
    Kearney MF; Wiegand A; Shao W; Coffin JM; Mellors JW; Lederman M; Gandhi RT; Keele BF; Li JZ
    J Virol; 2016 Feb; 90(3):1369-76. PubMed ID: 26581989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating CD30+CD4+ T Cells Increase Before Human Immunodeficiency Virus Rebound After Analytical Antiretroviral Treatment Interruption.
    Prator CA; Thanh C; Kumar S; Pan T; Peluso MJ; Bosch R; Jones N; Milush JM; Bakkour S; Stone M; Busch MP; Deeks SG; Hunt PW; Henrich TJ
    J Infect Dis; 2020 Mar; 221(7):1146-1155. PubMed ID: 31677350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid viral rebound after analytical treatment interruption in patients with very small HIV reservoir and minimal on-going viral transcription.
    Pannus P; Rutsaert S; De Wit S; Allard SD; Vanham G; Cole B; Nescoi C; Aerts J; De Spiegelaere W; Tsoumanis A; Couttenye MM; Herssens N; De Scheerder MA; Vandekerckhove L; Florence E
    J Int AIDS Soc; 2020 Feb; 23(2):e25453. PubMed ID: 32107887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.
    Pai NP; Lawrence J; Reingold AL; Tulsky JP
    Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD006148. PubMed ID: 16856117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Analytical Treatment Interruption on Burden and Diversification of HIV Peripheral Reservoir: A Pilot Study.
    Scutari R; Costabile V; Galli L; Bellocchi MC; Carioti L; Barbaliscia S; Poli A; Galli A; Perno CF; Santoro MM; Castagna A; Ceccherini-Silberstein F; Alteri C; Spagnuolo V
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study.
    Cummins NW; Rizza S; Litzow MR; Hua S; Lee GQ; Einkauf K; Chun TW; Rhame F; Baker JV; Busch MP; Chomont N; Dean PG; Fromentin R; Haase AT; Hampton D; Keating SM; Lada SM; Lee TH; Natesampillai S; Richman DD; Schacker TW; Wietgrefe S; Yu XG; Yao JD; Zeuli J; Lichterfeld M; Badley AD
    PLoS Med; 2017 Nov; 14(11):e1002461. PubMed ID: 29182633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.